- Home
- OMAB vs BHC Comparison
OMAB vs BHC Comparison
Compare OMAB & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMAB
- BHC
- Stock Information
- Founded
- OMAB 1998
- BHC N/A
- Country
- OMAB Mexico
- BHC Canada
- Employees
- OMAB N/A
- BHC N/A
- Industry
- OMAB Aerospace
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- OMAB Consumer Discretionary
- BHC Health Care
- Exchange
- OMAB Nasdaq
- BHC Nasdaq
- Market Cap
- OMAB 3.4B
- BHC 3.0B
- IPO Year
- OMAB 2006
- BHC N/A
- Fundamental
- Price
- OMAB $63.09
- BHC $8.59
- Analyst Decision
- OMAB Buy
- BHC Hold
- Analyst Count
- OMAB 2
- BHC 4
- Target Price
- OMAB $94.00
- BHC $7.25
- AVG Volume (30 Days)
- OMAB 61.2K
- BHC 2.0M
- Earning Date
- OMAB 10-25-2024
- BHC 10-30-2024
- Dividend Yield
- OMAB 5.07%
- BHC N/A
- EPS Growth
- OMAB 2.12
- BHC N/A
- EPS
- OMAB 0.66
- BHC N/A
- Revenue
- OMAB $748,989,666.00
- BHC $9,474,000,000.00
- Revenue This Year
- OMAB N/A
- BHC $9.59
- Revenue Next Year
- OMAB $7.13
- BHC $3.53
- P/E Ratio
- OMAB $11.93
- BHC N/A
- Revenue Growth
- OMAB 1.76
- BHC 10.91
- 52 Week Low
- OMAB $59.08
- BHC $3.96
- 52 Week High
- OMAB $90.53
- BHC $11.46
- Technical
- Relative Strength Index (RSI)
- OMAB 38.26
- BHC 49.98
- Support Level
- OMAB $64.15
- BHC $9.19
- Resistance Level
- OMAB $66.70
- BHC $9.49
- Average True Range (ATR)
- OMAB 2.10
- BHC 0.37
- MACD
- OMAB -0.19
- BHC -0.09
- Stochastic Oscillator
- OMAB 12.68
- BHC 33.24
About OMAB Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS
Grupo Aeroportuario del Centro Norte operates airports in the central region of Mexico. The largest airport is in Monterrey, which serves nearly half of the company's total passengers. In addition, the company manages two hotels and one industrial park.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.